Abstract
Drug-eluting stents (DES) have markedly reduced the incidence of coronary in-stent restenosis. However, DES may be still vulnerable to coronary thrombus, and the long-term outcome remains unknown, especially in infancy. Here, we present a 9-month-old infant, who developed severe stenosis of the left main coronary artery after surgery for Brand-White-Garland syndrome, and was successfully treated with DES. He was healthy and his cardiac function had improved to the normal level at 6 years old. An angiographic examination and computed tomography showed the complete persistence of DES and no evidence of intimal thickening.
This is a preview of subscription content, log in via an institution to check access.
References
Mavroudis C, Backer CL, Duffy CE, Pahl E, Wax DF (1999) Pediatric coronary artery bypass for Kawasaki, congenital, post arterial switch, and iatrogenic lesions. Ann Thorac Surg 68:506–512
Tsuda E, Kitamura S (2004) The cooperative study group of Japan. National survey of coronary artery bypass grafting for coronary stenosis caused by Kawasaki disease in Japan. Circulation 110(11 Suppl 1):61–66
Allada A, Jarmakani JM, Yeatman L (1991) Percutaneous transluminal coronal angioplasty in an infant with coronary artery stenosis after arterial switch operation. Am Heart J 122(5):1464–1465
Morice MC, Serruys PW, Barragan P, Bode C, Van Es GA, Stoll HP et al (2007) Long-term clinical outcomes with sirolimus-eluting coronary stents: Five-year results of the RAVEL trial. J Am Coll Cardiol 50(14):1299–1304
Roiron C, Sanchez P, Bouzamondo A, Lechat P, Montalescot G (2006) Drug eluting stents: An updated meta-analysis of randomised controlled trials. Heart 92(5):641–649
McFadden EP, Stabile E, Regar E, Cheneau E, Ong AT, Kinnaird T et al (2004) Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy. Lancet 364(9444):1519–1521
de la Torre-Hernández JM, Alfonso F, Hernández F, Elizaga J, Sanmartin M, Pinar E et al (2008) Drug-eluting stent thrombosis: Results from the multicenter Spanish registry ESTROFA (Estudio ESpañol sobre TROmbosis de stents FArmacoactivos). J Am Coll Cardiol 51(10):986–990
Dragulescu A, Ghez O, Quilici J, Fraisse A (2009) Paclitaxel drug-eluting stent placement for pulmonary vein stenosis as a bridge to heart-lung transplantation. Pediatr Cardiol 30(8):1169–1171
Jhang WK, Chang YJ, Park CS, Oh YM, Kim YH, Yun TJ (2008) Hybrid palliation for right atrial isomerism associated with obstructive total anomalous pulmonary venous drainage. Interact Cardiovasc Thorac Surg 7(2):282–284
Wong DT, Yoo SJ, Lee KJ (2008) Implantation of drug-eluting stents for relief of obstructed infra-cardiac totally anomalous pulmonary venous connection in isomerism of the right atrial appendages. Cardiol Young 18(6):628–630
Lemos PA, Saia F, Hofma SH, Daemen J, Ong AT, Arampatzis CA et al (2004) Short- and long-term clinical benefit of sirolimus-eluting stents compared to conventional bare stents for patients with acute myocardial infarction. J Am Coll Cardiol 43(4):704–708
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kaichi, S., Doi, H., Tsurumi, F. et al. Long-Term Outcome of Sirolimus-Eluting Stent Implantation for Left Main Coronary Artery Stenosis in Infancy. Pediatr Cardiol 32, 94–97 (2011). https://doi.org/10.1007/s00246-010-9815-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00246-010-9815-5